Connecting the Dots: Dietary Fat, Microbiota Dysbiosis, Altered Metabolome, and Colon Cancer

Microbiota-Derived Short-Chain Fatty Acids Boost Antitumoral Natural Killer Cell Activity

Background: The intestinal microbiota can regulate numerous host functions, including the immune response. Through fermentation, the microbiota produces and releases microbial metabolites such as short-chain fatty acids (SCFAs), which can affect host homeostasis. There is growing evidence that the gut microbiome can have a major impact on cancer. Specific gut microbial composition and metabolites are associated with tumor status in the host. However, their effects on the antitumor response have scarcely been investigated. Natural killer (NK) cells play an important role in antitumor immunity due to their ability to directly identify and eliminate tumor cells. Methods: The aim of this study was to investigate the effects of SCFAs on antitumoral NK cell activity, using NK-92 cell line. Results: Here, we describe how SCFAs can boost antitumoral NK cell activity. The SCFAs induced the release of NK extracellular vesicles and reduced the secretion of the anti-inflammatory cytokine IL-10. The SCFAs also increased the cytotoxicity of the NK cells against multiple myeloma cells. Conclusions: Our results indicate, for the first time, the enormous potential of SCFAs in regulating antitumoral NK cell defense, where modulation of the SCFAs' production could play a fundamental role in cancer immunotherapy.

Synergistic interactions and reaction mechanisms of biochar surface functionalities in antibiotics removal from industrial wastewater

Biochar, a carbon-rich material with a unique surface chemistry (high abundance of surface functional groups, large surface area, and well-distributed), has shown great potential as a sustainable solution for industrial wastewater treatment as compared to conventional industrial wastewater treatment techniques demand substantial energy consumption and generate detrimental byproducts. This critical review emphasizes the surface functionalities formation and development in biochar to enhance its physiochemical properties, for utilization in antibiotics removal. Factors affecting the formation of functionalities, including carbonization processes, feedstock materials, operating parameters, and the influence of pre-post treatments, are thoroughly highlighted to understand the crucial role of factors influencing biochar properties for optimal antibiotics removal. Furthermore, the research explores the removal mechanisms and interactions of biochar-based surface functionalities, hydrogen bonding, encompassing electrostatic interactions, hydrophobic interactions, π-π interactions, and electron donor and acceptor interactions, to provide insights into the adsorption/removal behavior of antibiotics on biochar surfaces. The review also explains the mechanism of factors influencing the removal of antibiotics in industrial wastewater treatment, including particle size and pore structure, nature and types of surface functional groups, pH and surface charge, temperature, surface modification strategies, hydrophobicity/hydrophilicity, biochar dose, pollutant concentration, contact time, and the presence of coexisting ions and other substances. Finally, the study offers reusability and regeneration, challenges and future perspectives on the development of biochar-based adsorbents and their applications in addressing antibiotics. It concludes by summarizing the key findings and emphasizing the significance of biochar as a sustainable and effective solution for mitigating antibiotics contamination in industrial wastewater.

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications

In the past period, due to the rapid development of next-generation sequencing technology, accumulating evidence has clarified the complex role of the human microbiota in the development of cancer and the therapeutic response. More importantly, available evidence seems to indicate that modulating the composition of the gut microbiota to improve the efficacy of anti-cancer drugs may be feasible. However, intricate complexities exist, and a deep and comprehensive understanding of how the human microbiota interacts with cancer is critical to realize its full potential in cancer treatment. The purpose of this review is to summarize the initial clues on molecular mechanisms regarding the mutual effects between the gut microbiota and cancer development, and to highlight the relationship between gut microbes and the efficacy of immunotherapy, chemotherapy, radiation therapy and cancer surgery, which may provide insights into the formulation of individualized therapeutic strategies for cancer management. In addition, the current and emerging microbial interventions for cancer therapy as well as their clinical applications are summarized. Although many challenges remain for now, the great importance and full potential of the gut microbiota cannot be overstated for the development of individualized anti-cancer strategies, and it is necessary to explore a holistic approach that incorporates microbial modulation therapy in cancer.

Research progress on the relationship between intestinal microecology and intestinal bowel disease

Intestinal microecology is the main component of human microecology. Intestinal microecology consists of intestinal microbiota, intestinal epithelial cells, and intestinal mucosal immune system. These components are interdependent and establish a complex interaction network that restricts each other. According to the impact on the human body, there are three categories of symbiotic bacteria, opportunistic pathogens, and pathogenic bacteria. The intestinal microecology participates in digestion and absorption, and material metabolism, and inhibits the growth of pathogenic microorganisms. It also acts as the body's natural immune barrier, regulates the innate immunity of the intestine, controls the mucosal barrier function, and also participates in the intestinal epithelial cells' physiological activities such as hyperplasia or apoptosis. When the steady‐state balance of the intestinal microecology is disturbed, the existing core intestinal microbiota network changes and leads to obesity, diabetes, and many other diseases, especially irritable bowel syndrome, inflammatory bowel disease (IBD), and colorectal malignancy. Intestinal diseases, including tumors, are particularly closely related to intestinal microecology. This article systematically discusses the research progress on the relationship between IBD and intestinal microecology from the pathogenesis, treatment methods of IBD, and the changes in intestinal microbiota.